Market Research Logo

GI Stool Testing Market 2015-2019 – Global Market Research

About GI stool testing

Normal gastrointestinal (GI) functioning is essential for digestion as well as for the removal of body waste and pathogens. GI disorders are a common problem in the general population. These disorders are known to cause severe harm to the health and quality of life of an individual. These disorders include malabsorption disorders, inflammatory bowel diseases, cancer of the digestive system, colitis, and gastroenteritis. Globally, about 1.7-2 billion cases of diarrheal diseases occur every year. Also, about 1,700 million cases of C. difficile infections have been reported worldwide every year.

Stool tests are used for the diagnosis of GI disorders and help detect parasite infection, inflammation, bleeding obstruction, and tumors in the GI tract and digestive system. The diagnosis of GI diseases is commonly done through laboratory tests using antigen or culture detection from stool samples. A stool test is of two categories: fecal occult blood test (FOBT) and clinical microbiological stool tests. These tests are either antibody-based or microbial particle-based detection methods, which include immunoassay, CLIA, and molecular diagnostic testing. Stool tests are used for the screening of colorectal cancer as well as the detection of pathogens such as C. difficile, H. pylora, Rotavirus, and Adenovirus.

The global GI stool testing market is expected to grow at a CAGR of 7.37% during 2014-2019.

Covered in this report

In this report, Technavio covers the present scenario and growth prospects of the global GI stool testing market for 2015-2019. To calculate the market size, we consider revenue generated from the sales of the following products:

  • FOBT
  • Clinical microbiology stool test
Technavio's report, Global GI Stool Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape of the global BI and analytics platform market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.Key regions
  • Americas
  • APAC
  • EMEA
Key vendors
  • Clinical Genomics
  • Diasorin
  • Meridian Bioscience
  • Quidel
Other prominent vendors
  • Alere
  • Beckman Coulter
  • bioMérieux
  • Bio-Rad Laboratories
  • CARE Products
  • Cenogenics
  • EIKEN CHEMICAL
  • Epigenomics
  • Epitope Diagnostic
  • Exact Sciences
  • Helena Laboratories
  • Hemosure
  • Mobidiag
  • Orion Diagnostica
  • Pinnacle BioLabs
  • Polymedco
  • Propper Manufacturing
  • ScheBo Biotech
  • Trinity Biotech
Key market driver
  • Increased incidence of C. difficile infections
  • For a full, detailed list, view our report
Key market challenge
  • Accurate diagnostic testing
  • For a full, detailed list, view our report
Key market trend
  • Focus on rapid and early diagnosis
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
    • Top-vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
  • Market landscape
    • Market overview
    • Market size and forecast
      • Table Global gastrointestinal stool testing market ($ millions)
    • Five forces analysis
  • Reimbursement and coverage: An overview
    • Current scenario: Validating diagnostic tests
    • Reimbursement structure in the US
    • Reimbursement structure in EU
    • Prevailing issues of reimbursement policies
      • Table Reimbursement perspectives of healthcare entities
  • Gastrointestinal stool tests: Present and future technology
  • Market segmentation by product
    • Table Global gastrointestinal stool testing market segmentation by product
    • Reagents
    • Instruments
      • Table Global gastrointestinal stool testing market segmentation by product 2014
  • Market segmentation by application
    • Table Global gastrointestinal stool testing market segmentation by application
    • Colorectal cancer
    • Diarrhea
    • Gastrointestinal tract infections
    • Others
  • Market segmentation by technology
    • Table Global gastrointestinal stool testing market segmentation by technology
  • Market segmentation by test
    • Table Global gastrointestinal stool testing market segmentation by test
  • Geographical segmentation
    • Global gastrointestinal stool testing market segmentation by geography
      • Table Global gastrointestinal stool testing market segmentation by geography 2014
      • Table Global gastrointestinal stool testing market segmentation by geography 2019
      • Table Global gastrointestinal stool testing market by geography 2014-2019
    • Gastrointestinal stool testing market in Americas
      • Table Gastrointestinal stool testing market in Americas ($ millions)
    • Gastrointestinal stool testing market in EMEA
      • Table Gastrointestinal stool testing market in EMEA ($ millions)
    • Gastrointestinal stool testing market in APAC
      • Table Gastrointestinal stool testing market in APAC ($ millions)
  • Market drivers
    • Increased incidence of Clostridium difficile infections
    • Automation and system integration
    • Early diagnosis of colorectal cancer
    • Focus on emerging countries
      • Table Healthcare spending by country 2015 ($ billions)
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • Accurate diagnostic testing
    • Business and regulatory issues
    • Alternatives to stool tests
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Rapid and early diagnosis
    • Use of point-of-care tests
    • Increase in public awareness
  • Vendor landscape
    • Competitive scenario
    • Market share analysis 2014
      • Table Clinical Genomics: Key takeaways
      • Table DiaSorin: Key takeaways
      • Table Meridian Bioscience: Key takeaways
      • Table Quidel: Key takeaways
    • Other prominent vendors
  • Key vendor analysis
    • Clinical Genomics
      • Table Clinical Genomics: Product categories
    • DiaSorin
      • Table DiaSorin: Business segmentation by revenue 2014
      • Table DiaSorin: Business segmentation by revenue 2013 and 2014
      • Table DiaSorin: Geographical segmentation by revenue 2014
    • Meridian Bioscience
      • Table Meridian Bioscience: Business segmentation by revenue 2014
      • Table Meridian Bioscience: Business segmentation by revenue 2013 and 2014 ($ millions)
      • Table Meridian Bioscience: Geographical segmentation by revenue 2014
    • Quidel
      • Table Quidel: Product segmentation by revenue 2014
      • Table Quidel: Product segmentation by revenue 2013 and 2014 ($ millions)
      • Table Quidel: Geographical segmentation by revenue 2014
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report